Sarepta Therapeutics (SRPT)

• Market cap: $1.82B
• 1 day: -3.12%
• 5 days: -1.08%
• 1 month: -17.69%
• 3 months: -3.33%
• 6 months: -7.45%
• Year to date: -18.35%
• 1 year: -84.15%
• 5 years: -80.89%
• 10 years: 40.89%
• Sector: Healthcare
• Industry: Biotechnology

About: Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Employees: 1,372